Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mach7 Technologies ( (AU:M7T) ) has provided an update.
Mach7 Technologies has announced the date for its 2025 Annual General Meeting, scheduled for November 28, 2025, in Melbourne. This meeting will be crucial for stakeholders as it includes the closing date for director nominations, which is set for October 10, 2025, potentially impacting the company’s leadership and strategic direction.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.81 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is a leading provider of medical imaging software, offering advanced data management and diagnostic viewing solutions to healthcare organizations globally. Their Mach7 Enterprise Imaging Solution (EIS) combines a Vendor Neutral Archive (VNA), the eUnity Enterprise Diagnostic Viewer, and diagnostic workflow applications, catering to a diverse network from large integrated delivery networks to private radiology practices.
Average Trading Volume: 265,493
Technical Sentiment Signal: Sell
Current Market Cap: A$75.19M
Find detailed analytics on M7T stock on TipRanks’ Stock Analysis page.